Red X iconGreen tick iconYellow tick icon
Skip to main content Skip to side navigation
  • Barclay ML, Patton N, Kirkpatrick CMJ, Moore JA, Doogue MP. Population pharmacokinetic analysis of high-dose oral busulphan for bone marrow transplantation in adults and children. 8th World Conf Clin Pharmacol Ther 2004; 31(1), 174 [Abstract]
  • Doogue MPD, Gardiner SJ, Begg EJ. Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother 2004; 38(1), 172-7 (Letter) [ref]
  • Ilett KF, Hackett LP, Kristensen JH, Vaddadi K, Gardiner SJ, Begg EJ. Transfer of risperidone and 9-hydroxyrisperidone into human milk: three case studies. Ann Pharmacother 2004; 38(2), 273-6 [Abstract]
  • Begg EJ. Individualising drug therapy, and 'men behaving badly'. Br J Clin Pharmacol 2004; 58(5),449-51 (Editorial) [ref]
  • Aronson JK, Lennard MS, Ritter JM, Baber NS, Begg EJ. The British Journal Clinical Pharmacology Editors' report for 2003. Br J Clin Pharmacol 2004; 57(5), 538-9 [Abstract]
  • Roberts RL, Barclay ML, Gearry RB, Kennedy MA. A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations. Clin Chim Acta 2004; 341(1), 49-53 [Abstract]
  • Gearry RB, Wakeman CJ, Barclay ML, Chapman BA, Collett JA, Burt MJ, Frizelle FA. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand. Dis Colon Rectum 2004; 47(3), 314-22 [Abstract]
  • Vella-Brincat JW, Begg EJ, Gallagher K, Kirkpatrick CM, Zhang M, Frampton C, Chambers ST. Stability of benzylpenicillin during continuous home intravenous therapy. J Antimicrob Chemother 2004; 53(4), 675-7 [Abstract]
  • Zhang M, Moore GA, Gardiner SJ, Begg EJ. Determination of rofecoxib in human plasma and breast milk by high-performance liquid chromatographic assay. J Chromatogr B 2004; 807(2), 217-21 [Abstract]
  • Roberts RL, Gearry RB, Barclay ML, Kennedy MA. Rapid detection of common CARD15 variants in patients with inflammatory bowel disease. Mol Diagn 2004; 8(2), 101-5 [Abstract]
  • Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2004; 13(8), 563-7 [Abstract]
  • Gardiner SJ, Begg EJ. Genotyping for drug-metabolizing enzymes--does the promise meet the reality? Pharmacogenomics 2004; 5(8), 1033-6 [Ref]
  • Gearry RB, Roberts RL, Barclay ML, Kennedy MA. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenet Genomics 2004; 14(11), 779-81 [Abstract]
  • Vella-Brincat J, Macleod AD. Haloperidol in palliative care. Palliat Med 2004; 18(3), 195-201 [Abstract]
  • Gardiner SJ, Begg EJ, Kirkpatrick CMJ, Buckham RB. Metformin therapy and diabetes in pregnancy. Med J Aust 2004; 181(3), 174-5 [letter]
  • Gardiner SJ, Begg EJ. Pharmacogenetics 'down under' – is it happening? Clin Exp Pharmicol Physiol 2004; 31(11), A229 [No abstract]
  • Gardiner S, Kirkpatrick CMJ, McCrae E, Shaw E. The Dispensing Guide2004 (Book). Pharm Soc NZ, 6th edition [Ref]
  • Frizelle FA, Gearry RB, Johnston M, Barclay ML, Dobbs BR, Wise C, Troughton WD. Penile and clitoral stimulation for faecal incontinence: external application of a bipolar electrode for patients with faecal incontinence. Colorectal Dis 2004; 6(1), 54-7 [Abstract]

Back to top